Oncolytics Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.80

+0.00 (+0.24%)

As of Aug 15, 2:14 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +2,415.9% upside

Low Target $14.44

Average Target $20.19

High Target $28.89

Current Price $0.80

Current
$0.80

Target
$20.19

$14.44 $20.19 avg $28.89

Scenario Analysis

Bear Case

$14.44

1,699.4%

Low target

Base Case

$20.19

+2,415.9%

Avg target

Bull Case

$28.89

+3,500.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$1.50

-46.5% from high

52-Week Low

$1.14

+-29.6% from low

Target vs 52W High

$20.19

+1,246.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%